Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Neuroscience Antibodies & Assays Market Grown from 2024 to 2025?
The market size for neuroscience antibodies and assays has seen significant expansion recently. The market, which sat at $4.52 billion in 2024, is projected to reach $5.07 billion in 2025, with a compound annual growth rate (CAGR) of 12.2%. The previous growth pattern can be linked to elements such as research funding, the discovery and development of drugs, neurodegenerative diseases, government actions, and the progression of personalized medicine.
What Growth Rate Is Anticipated for the Neuroscience Antibodies & Assays Market in the Coming Years?
Anticipations are high for the neuroscience antibodies & assays market, as it is projected to experience swift expansion in the upcoming years. The market value is predicted to reach $8.74 billion by 2029, with an impressive CAGR of 14.6%. Factors contributing to this projected growth during the forecast period involve collaborations, the application of telemedicine in neurology, education and training, biomarker-driven therapies, and a focus on neuroimmunology. The forecast period is also expected to see trends like microrna and non-coding rna assays, digital pathology, advanced imaging-compatible assays, single-cell analysis, and 3D organoid models.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7548&type=smp
Who Are the Leading Companies in the Neuroscience Antibodies & Assays Market?
Major companies operating in the neuroscience antibodies & assays market include Abcam plc, BioLegend Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Merck KGaA, Rockland Immunochemicals Inc., GenScript Biotech Corporation, Santa Cruz Biotechnology Inc., Wak-Chemie Medical GmbH, Epitope Diagnostics Inc., Agilent Technologies, Bio-Techne Corporation, Creative Diagnostics, Enzo Life Sciences Inc., Jackson ImmunoResearch Laboratories Inc., Novus Biologicals LLC, OriGene Technologies Inc., Proteintech Group Inc., R&D Systems Inc., RayBiotech Inc., StressMarq Biosciences Inc., Synaptic Systems GmbH, Tocris Bioscience, Alomone Labs Ltd., AnaSpec Inc., Antibodies.com, Antibody Solutions, Arbor Assays, Uscn Life Science Inc., Zymo Research Corp., AAT Bioquest Inc., Abbexa Ltd., ACROBiosystems Inc., Active Motif Inc., AdipoGen Life Sciences, Advanced Targeting Systems Inc., AgriSera AB
What Are the Key Drivers of the Neuroscience Antibodies & Assays Market?
The global rise in neurological ailments is anticipated to spur the expansion of the neuroscience antibodies & assays market. Neurological maladies, which disrupt the functioning of the nervous system, encompass conditions like epilepsy, Alzheimer’s disease, dementia, and so on. With the escalating instances of such neurological diseases, there’s an increasing need for in-depth research and advanced healthcare solutions for these conditions. The usage of antibodies and assays in research plays a significant role in studying the development, systems, structure, functionality, disorders, and degeneration within the nervous system. Consequently, the growth of the neuroscience antibodies & assays market is positively linked with the increasing instances of neurological diseases. In May 2024, as reported by the Centers for Disease Control and Prevention, a federal agency based in the US, approximately 2.9 million American adults aged 18 and above were found to have active epilepsy during 2021 and 2022. According to the 2022 data shared by Alzheimer’s Association, a US-based non-profit organization, about 6.5 million people in the US suffer from Alzheimer’s disease. Hence, the mounting prevalence of neurological ailments worldwide is propelling the progress of the neuroscience antibodies and assays market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=7548&type=smp
What Are the Key Market Segments in the Neuroscience Antibodies & Assays Industry?
The neuroscience antibodies & assays market covered in this report is segmented –
1) By Product: Consumables, Instruments
2) By Technology: Molecular Diagnostics, Clinical Chemistry, Immunoassays Or Immunochemistry, Others Technologies
3) By Application: In Vitro Diagnostics, Research, Drug Discovery
4) By End User: Hospitals And Diagnostics Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies
Subsegments:
1) By Consumables: Antibodies, Assay Kits, Assay Kits
2) By Instruments: Spectrophotometers, Microplate Readers, Flow Cytometers, Western Blotting Systems, Imaging Systems, Automated Workstations
What Are the Latest Trends in the Neuroscience Antibodies & Assays Market?
The emergence of cutting-edge technologies is a prevailing trend in the neuroscience antibodies and assays market. Significant market players are adopting innovative technologies like NeuroNexus Summa Framework technology to maintain their dominance in the market. For example, NeuroNexus Technologies, an American company specializing in novel neural interface products and technologies, announced the introduction of the NeuroNexus Summa Framework in February 2022. This solution was crafted for experienced electrophysiologists and life science researchers, enabling them to effortlessly integrate electrical signal read-outs from biological cells and tissues into their research process.
Access The Full Report Here:
What Are the Key Regional Markets in the Neuroscience Antibodies & Assays Industry?
North America was the largest region in the neuroscience antibodies & assays market in 2024. The regions covered in the neuroscience antibodies & assays market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7548
This Report Delivers Insight On:
1. How big is the neuroscience antibodies & assays market, and how is it changing globally?
2. Who are the major companies in the neuroscience antibodies & assays market, and how are they performing?
3. What are the key opportunities and risks in the neuroscience antibodies & assays market right now?
4. Which products or customer segments are growing the most in the neuroscience antibodies & assays market?
5. What factors are helping or slowing down the growth of the neuroscience antibodies & assays market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model